Sponsor Check › Agitated Solutions › Issuer
Corporation · organized in DELAWARE · formed Over five years ago · Saint Paul, MN · SEC CIK 1850720
Part of sponsor group: Agitated Solutions (2 issuers, 6 filings) · grouped because: shared people, similar issuer names · confidence 100% · Not the same sponsor? Request a correction
Data last updated: Oct 23, 2026, 5:45 PM ET · Latest filing by this issuer: Oct 20, 2026 · Courts (RECAP) last checked: not yet · SEC enforcement last checked: not yet
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
Not yet searched.
Sources to be searched: CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
Not yet searched.
Sources to be searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. State securities regulator actions: not yet searched. · Search queued. Results are added automatically; check back later or follow this page to be notified.
Not yet searched.
Sources to be searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
Coming soon.
What will be compared: what the sponsor says publicly (website, marketing materials, claimed profile) against what public records show — SEC Form D filings, Form ADV adviser registration, and state business records. Every comparison is reviewed by a person before it is published.
No comparisons published yet.
Sources to be compared: sponsor public claims · SEC Form D · SEC Form ADV (IAPD) · state business records · As of Oct 23, 2026, 9:12 PM ET.
0 of 4 offerings report sales commissions; 0 report finder's fees; 0 report proceeds to related persons.
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Mar 11, 2021 D File 021-391914 | $0 | $0 | $0 | None listed |
| EDGAR ↗ | Mar 18, 2022 D File 021-437939 | $0 | $0 | $0 | None listed |
| EDGAR ↗ | Apr 15, 2022 D File 021-442049 | $0 | $0 | $0 | None listed |
| EDGAR ↗ | Oct 20, 2026 D/A File 021-561711 | $0 | $0 | $0 | None listed |
As reported by the issuer on Form D (Items 12–15), latest filing per offering. "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates.
Each filing as reported by the issuer. Open a row for the full plain-English detail.
| Filing | Form D/A (amendment) filed Oct 20, 2026 · amends 0001437749-25-031521 ↗ SEC file no. 021-561711 · accession 0001437749-26-032976 |
|---|---|
| Raise progress | $6,385,126 sold of $13,810,913 offered (46%) · $7,425,787 remaining 13(a) and (b) includes the conversion of approximately $3,810,924 in previously issued convertible notes and accrued interest; 13(a) and (c) includes the issuance of warrants. |
| Filing timing | Date of first sale: Jul 24, 2025 · Form D filed: Oct 20, 2026 (453 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 457 days (1.3 years) |
| Annual amendments | Issuer reported the offering may last more than one year. This filing is an amendment dated Oct 20, 2026. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 53 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Equity; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Morgan E. Evans, Chief Executive Officer (Oct 19, 2026) |
| Changes vs prior filing | total sold: $6,513,312 → $6,385,126 total offering: $13,742,657 → $13,810,913 investors: 44 → 53 Compared with the D filed Oct 22, 2025 (EDGAR ↗). Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0. Typical range for similar offerings: $10,000–$54,310. Offering size: $13,810,913. Typical range: $829,831–$9,999,998. Investors: 53. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the EDGAR daily index |
| Filing | Form D filed Oct 22, 2025 SEC file no. 021-561711 · accession 0001437749-25-031521 |
|---|---|
| Raise progress | $6,513,312 sold of $13,742,657 offered (47%) · $7,229,345 remaining 13(a) and (b) includes the conversion of approximately $3,810,924 in previously issued convertible notes and accrued interest; 13(a) and (c) includes the issuance of warrants. |
| Filing timing | Date of first sale: Jul 24, 2025 · Form D filed: Oct 22, 2025 (90 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 457 days (1.3 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 44 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Equity; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Morgan E. Evans, Chief Executive Officer (Oct 22, 2025) |
| Market context | Minimum investment: $0. Typical range for similar offerings: $10,000–$54,310. Offering size: $13,742,657. Typical range: $829,831–$9,999,998. Investors: 44. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D filed Apr 15, 2022 SEC file no. 021-442049 · accession 0001850720-22-000002 |
|---|---|
| Raise progress | $1,175,009 sold of $3,500,000 offered (34%) · $2,324,991 remaining |
| Filing timing | Date of first sale: Apr 12, 2022 · Form D filed: Apr 15, 2022 (3 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 1,656 days (4.5 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 15 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(c) — general advertising allowed; all investors must be verified accredited |
| Minimum investment accepted | $25,000 |
| Securities offered | Equity |
| Industry / issuer size | Other Health Care · revenue range: No Revenues |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | ROBERT A. KUKULJAN, SECRETARY (Apr 14, 2022) |
| Market context | Minimum investment: $25,000. Typical range for similar offerings: $25,000–$100,000. Offering size: $3,500,000. Typical range: $1,500,000–$10,000,000. Investors: 15. Typical range: 1–11. "Similar" = Other Health Care offerings claiming 506(c) filed in the last 5 years (171 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D filed Mar 18, 2022 SEC file no. 021-437939 · accession 0001850720-22-000001 |
|---|---|
| Raise progress | $1,574,982 sold of $1,574,982 offered (100%) · $0 remaining |
| Filing timing | Date of first sale: Mar 18, 2022 · Form D filed: Mar 18, 2022 (0 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 1,681 days (4.6 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 24 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(c) — general advertising allowed; all investors must be verified accredited |
| Minimum investment accepted | $25,000 |
| Securities offered | Equity |
| Industry / issuer size | Other Health Care · revenue range: No Revenues |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Robert A. Kukuljan, Secretary (Mar 18, 2022) |
| Market context | Minimum investment: $25,000. Typical range for similar offerings: $25,000–$100,000. Offering size: $1,574,982. Typical range: $1,500,000–$10,000,000. Investors: 24. Typical range: 1–11. "Similar" = Other Health Care offerings claiming 506(c) filed in the last 5 years (171 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D filed Mar 11, 2021 SEC file no. 021-391914 · accession 0001850720-21-000001 |
|---|---|
| Raise progress | $80,000 sold of $1,300,000 offered (6%) · $1,220,000 remaining |
| Filing timing | Date of first sale: Mar 5, 2021 · Form D filed: Mar 11, 2021 (6 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 2,059 days (5.6 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 2 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(c) — general advertising allowed; all investors must be verified accredited |
| Minimum investment accepted | $10,000 |
| Securities offered | Debt; Security to be acquired upon exercise |
| Industry / issuer size | Other Health Care · revenue range: No Revenues |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Morgan Clyburn, President (Mar 11, 2021) |
| Market context | Minimum investment: $10,000. Typical range for similar offerings: $25,000–$100,000. Offering size: $1,300,000. Typical range: $1,500,000–$10,000,000. Investors: 2. Typical range: 1–11. "Similar" = Other Health Care offerings claiming 506(c) filed in the last 5 years (171 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
All Form D filings for this CIK on SEC EDGAR ↗. History: 0 new offerings in the last 12 months · most recent filing Oct 20, 2026.
| Name | Relationship | Address state | On filings | Also listed on |
|---|---|---|---|---|
| Gerald Mattys | Director | MN | Oct 20, 2026 | 3 other issuers |
| Kathleen Tune | Director | MN | Oct 20, 2026 | 2 other issuers |
| Mark Pacyna | Director | MN | Oct 20, 2026 | 1 other issuer |
| Micah Elmer | Director | MN | Oct 20, 2026 | — |
| Morgan E. Evans | Executive Officer, Director | MN | Oct 22, 2025 → Oct 20, 2026 | — |
| Gerald E. Mattys | Director | MN | Oct 22, 2025 | — |
| Kathleen E. Tune | Director | MN | Oct 22, 2025 | 1 other issuer |
| Mark E. Pacyna | Director | MN | Oct 22, 2025 | — |
| Micah E. Eimer | Director | MN | Oct 22, 2025 | — |
| KATHLEEN A. TUNE | Director | MN | Apr 15, 2022 | 2 other issuers |
| MARK A. PACYNA | Director | MN | Apr 15, 2022 | 1 other issuer |
| MICAH A. EIMER | Director | MN | Apr 15, 2022 | — |
| MORGAN EVANS | Executive Officer, Director | MN | Apr 15, 2022 | 4 other issuers |
| ROBERT A. KUKULJAN | Executive Officer | MN | Apr 15, 2022 | 7 other issuers |
| Kathleen A. Tune | Director | MN | Mar 11, 2021 → Mar 18, 2022 | 2 other issuers |
| Mark A. Pacyna | Director | MN | Mar 11, 2021 → Mar 18, 2022 | 1 other issuer |
| Micah A. Eimer | Director | MN | Mar 11, 2021 → Mar 18, 2022 | — |
| Morgan Evans | Executive Officer, Director | MN | Mar 18, 2022 | 4 other issuers |
| Robert A. Kukuljan | Executive Officer | MN | Mar 11, 2021 → Mar 18, 2022 | 7 other issuers |
| Morgan Clyburn | Executive Officer, Director | MN | Mar 11, 2021 | — |
Executive officers, directors and promoters as self-reported by the issuer. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗.
Other issuers listing the same people:
Shared address: this business address appears on no other issuer's filings in our index.
Not yet searched. Sources to be searched: SEC Investment Adviser Public Disclosure (IAPD) firm search — registered and exempt reporting advisers · Search queued. Results are added automatically; check back later.
Not yet collected. We store official links only (company website, verified via a profile claim) and the earliest archived date of the website; never personal or family accounts.
Export this report as PDF (all source links + data timestamp; members)
No corrections have been requested for this page.
The complete public-record profile for AGITATED SOLUTIONS, INC., plus the weekly new-filings list.
Only "Connect me" shares your details — with this sponsor, at a flat price we charge them, never tied to whether you invest. "Just researching" shares nothing.
Free. Tell us what's wrong and, if you can, where the correct public record is. Every request is logged with its status (received → under review → fixed / confirmed with source).
Sponsors may add a sourced explanation next to any fact on this page. Reviewed before publishing; never edits the public record.
Free. Get the "Claimed by sponsor" chip and a verified contact for corrections. Claiming never changes the public-record section.